Fischer Medical Ventures (Fischer MV) has formalised its investment in Health Digital Technologies (HDT), joining their existing investors Samsung Ventures and sovereign wealth fund of Malaysia, Khazanah (through MTDC), to bring their teleconsultation platform and e-prescription pharmacy, i.e. DoctorOnCall, beyond Malaysia market.
HDT is leading Malaysia's digital healthcare evolution through DoctorOnCall, the nation's pioneering integrated platform offering a comprehensive healthcare ecosystem, seamlessly merging teleconsultations, online pharmacy services, a dynamic health services marketplace, cutting-edge insurance solutions, and bespoke corporate medical concierge services, all in 1 platform. With a robust infrastructure encompassing more than 500 GP clinics network, engaging over 1.9 million registered users, and supporting more than 20 million annual visits, DoctorOnCall platform has redefined healthcare accessibility and convenience, with an intuitive interface that integrates teleconsultations, online pharmacy services, health services bookings, and bespoke medical concierge services.
At the core of HDT’s innovation lies the Digital Health Exchange (DHX) platform, a game-changing solution that aggregates healthcare services from multiple providers, ensuring unparalleled service integration across the sector. Through technological innovation, HDT bridges the gap between patients, healthcare providers, and insurers, setting new benchmarks in accessibility, efficiency, and quality care in the digital age. This strategic partnership between Fischer MV and HDT exemplifies a joint commitment to innovation, accessibility, and excellence in digital healthcare delivery, setting a new benchmark for the industry globally, with a commitment to innovation, affordability, and quality.
Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.
Company Name | CMP |
---|---|
Tata Chemicals | 1069.40 |
SRF | 2165.85 |
Pidilite Inds. | 2958.60 |
Aarti Inds | 430.80 |
Atul | 7261.00 |
View more.. |